Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.672, 2013-01, pp. : 2-2
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Etanercept or infliximab: costs to US Medicare
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 276, 2000-01 ,pp. :
Access to resources
Recommend
Chronic conditions contribute to Medicare costs
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 599, 2010-01 ,pp. :
Etanercept or infliximab: costs to US Medicare
Inpharma, Vol. 1, Iss. 1251, 2000-01 ,pp. :
OOP costs high among Medicare beneficiaries with cancer
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 670, 2013-01 ,pp. :
Clinical pharmacists reduce institutional costs
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 321, 2001-01 ,pp. :